Compugen Stock Investor Sentiment

CGEN Stock  USD 1.54  0.05  3.14%   
About 61% of Compugen's investor base is looking to short. The analysis of overall sentiment of trading Compugen stock suggests that many investors are alarmed at this time. Compugen's investing sentiment overview a quick insight into current market opportunities from investing in Compugen. Many technical investors use Compugen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Compugen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Compugen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Compugen's Stock prices. Below is the latest headlines and news related to Compugen Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. This information is accessible both publicly - through Compugen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Compugen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.

Compugen Largest EPS Surprises

Earnings surprises can significantly impact Compugen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2011-11-08
2011-09-30-0.09-0.1-0.0111 
2011-05-11
2011-03-31-0.07-0.060.0114 
2010-02-09
2009-12-31-0.08-0.070.0112 
2009-10-27
2009-09-30-0.07-0.060.0114 
2023-11-07
2023-09-30-0.09-0.11-0.0222 
2020-07-30
2020-06-30-0.1-0.080.0220 
View All Earnings Estimates
2 days ago at news.google.com         
What drives Compugen Ltd. stock price - Unmatched profit potential - Jammu Links News
Google News at Macroaxis
3 days ago at news.google.com         
Is Compugen Ltd. a good long term investment - Triple-digit wealth increases - Jammu Links News
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Taylor Frigon Capital Management LLC Sells 43,751 Shares of Compugen Ltd.
news
over three weeks ago at zacks.com         
Graham Surges 7.4 percent Is This an Indication of Further Gains?
zacks News
over three weeks ago at zacks.com         
Strength Seen in Brainsway Can Its 5.3 percent Jump Turn into More Strength?
zacks News
over a month ago at finance.yahoo.com         
Sage Therapeutics Soars 35.4 percent Is Further Upside Left in the Stock?
Yahoo News
over a month ago at gurufocus.com         
Compugen to Present AIML Driven Predictive Computational Research at Upcoming International ...
Gurufocus Stories at Macroaxis
over a month ago at businesswire.com         
DESTINY-Endometrial01 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2...
businesswire News
over a month ago at finance.yahoo.com         
DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients wit...
Yahoo News
over a month ago at simplywall.st         
Analysts Just Shaved Their Compugen Ltd. Forecasts Dramatically
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
These Analysts Just Made An Incredible Downgrade To Their Compugen Ltd. EPS Forecasts
Yahoo News
over two months ago at insidermonkey.com         
Compugen Ltd. Q1 2025 Earnings Call Transcript
insidermonkey News
over two months ago at finance.yahoo.com         
Compugen First Quarter 2025 Earnings Misses Expectations
Yahoo News
over two months ago at simplywall.st         
Compugen First Quarter 2025 Earnings Misses Expectations
Simply Wall St News at Macroaxis
over two months ago at gurufocus.com         
Compugen Ltd Q1 2025 Earnings Call Highlights Strategic Advances Amid Revenue Decline
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. This information is accessible both publicly - through Compugen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Compugen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.

Compugen Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Regenxbio Q1 Earnings and Revenues Lag Estimates
05/12/2025
2
Compugen Announces Leadership Transitions Effective September 2025 CGEN Stock News
05/13/2025
3
Compugen Q1 2025 Earnings Preview
05/16/2025
4
Compugen Posts Quarterly Earnings Results, Misses Expectations By 0.02 EPS
05/19/2025
5
Compugen Ltd Q1 2025 Earnings Call Highlights Strategic Advances Amid Revenue Decline
05/20/2025
6
Compugen to Present AIML Driven Predictive Computational Research at Upcoming International ...
06/12/2025
7
Graham Surges 7.4 percent Is This an Indication of Further Gains
06/24/2025
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Compugen Hype Analysis, Compugen Correlation and Compugen Performance.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.16)
Revenue Per Share
0.306
Quarterly Revenue Growth
(0.11)
Return On Assets
(0.08)
Return On Equity
(0.24)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.